[X1ANNEX XVII U.K. [F1RESTRICTIONS ON THE MANUFACTURE, PLACING ON THE MARKET AND USE OF CERTAIN DANGEROUS SUBSTANCES, MIXTURES AND ARTICLES]

Editorial Information

Textual Amendments

Appendix 6 [F1Entry 30 — Toxic to reproduction: category 1B (Table 3.1)/category 2 (Table 3.2)]

ANNEX XVII Table 6: rows 201 - 214

[X1(2RS,3RS)-3-(2-Chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)-methyl]oxirane 613-175-00-9 406-850-2 106325-08-0

[F2Epoxiconazole (ISO);

(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1 H -1,2,4-triazol-1-yl)methyl]oxirane

613-175-00-9 406-850-2 133855-98-8 ]
3-Ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine 613-191-00-6 421-150-7 143860-04-2

A mixture of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione;

a mixture of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione

613-199-00-X 421-550-1 —

[F3Ketoconazole;

1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone

613-283-00-6 265-667-4 65277-42-1

Potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;

[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]

613-286-01-X 418-260-2 183196-57-8 ]
N, N-dimethylformamide; dimethyl formamide 616-001-00-X 200-679-5 68-12-2
N, N-Dimethylacetamide 616-011-00-4 204-826-4 127-19-5 [F4E]
Formamide 616-052-00-8 200-842-0 75-12-7
N-methylacetamide 616-053-00-3 201-182-6 79-16-3
N-methylformamide 616-056-00-X 204-624-6 123-39-7 [F4E]
[F3N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide 616-148-00-X 424-550-1 84245-12-5
N,N-(dimethylamino)thioacetamide hydrochloride 616-180-00-4 435-470-1 27366-72-9 ]
[F2N-ethyl-2-pyrrolidone; 1-ethylpyrrolidin-2-one 616-208-00-5 220-250-6 2687-91-4 ] ]

Textual Amendments

Textual Amendments